Your browser doesn't support javascript.
loading
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study.
Grob, Jean Jacques; Jouary, Thomas; Dréno, Brigitte; Asselineau, Julien; Gutzmer, Ralf; Hauschild, Axel; Leccia, Marie Thérèse; Landthaler, Michael; Garbe, Claus; Sassolas, Bruno; Herbst, Rudolf A; Guillot, Bernard; Chene, Genevieve; Pehamberger, Hubert.
Affiliation
  • Grob JJ; Aix-Marseille University, CRO2, Service de Dermatologie, Hopital de Timone, 264 Rue St Pierre, 13885 Marseille CEDEX 05, Marseille, France. jean-jacques.grob@ap-hm.fr
Eur J Cancer ; 49(1): 166-74, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22975216
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Skin Neoplasms / Interferon-alpha / Melanoma / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2013 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Skin Neoplasms / Interferon-alpha / Melanoma / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2013 Document type: Article Affiliation country: France Country of publication: United kingdom